Novavax to Participate in 2026 Jefferies Global Healthcare Conference - Jun 1, 2026

GAITHERSBURG, Md. , June 1, 2026 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX) today announced it will participate in the 2026 Jefferies Global Healthcare Conference.

Conference Details:

Fireside Chat

Date:

Thursday, June 4, 2026

Time:

10:30 – 11:00 a.m. Eastern Time

Location:

New York, NY

Recordings A webcast of the fireside chat will be available on the Events & Presentations page of the Company's website at ir.novavax.com . A replay of the webcast will be available for 30 days.

About Novavax Novavax, Inc. (Nasdaq: NVAX) tackles some of the world's most pressing health challenges with its scientific expertise in vaccines and its proven technology platform, including its Matrix-M ® adjuvant and protein-based nanoparticles. The Company's corporate growth strategy is designed to deliver value via three key strategic pillars: partnering its technology, capital-efficient research and development (R&D) innovation and a lean and efficient operating model. This includes maximizing impact through partnerships for its marketed products (Nuvaxovid, R21/Matrix-M™), Matrix technology and R&D assets. Please visit novavax.com and LinkedIn for more information.

Contacts: Investors Jim Kelly 844-668-2829 [email protected]

Media Yvonne Sprow 844-264-8571 [email protected]

SOURCE Novavax, Inc.